Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 143,623 | 499 | 412 | 516 | 1,254 |
| Gross Profit | 143,623 | 499 | 412 | 516 | 1,254 |
| Operating Expenses | 47,361 | 55,275 | 39,392 | 64,903 | 52,611 |
| Operating Income | 96,262 | -54,776 | -38,980 | -64,387 | -51,357 |
| Other Income | 1,322 | 1,884 | 2,333 | 2,957 | 3,455 |
| Pre-tax Income | 97,584 | -52,892 | -36,647 | -61,430 | -47,902 |
| Net Income Continuous | 97,584 | -52,892 | -36,647 | -61,430 | -47,902 |
| Net Income | $97,584 | $-52,892 | $-36,647 | $-61,430 | $-47,902 |
| EPS Basic Total Ops | 1.59 | -0.86 | -0.61 | -1.01 | -0.79 |
| EPS Basic Continuous Ops | 1.59 | -0.86 | -0.60 | -1.01 | -0.79 |
| EPS Diluted Total Ops | 1.58 | -0.86 | -0.61 | -1.01 | -0.79 |
| EPS Diluted Continuous Ops | 1.58 | -0.86 | -0.60 | -1.01 | -0.79 |
| EPS Diluted Before Non-Recurring Items | 1.58 | -0.86 | -0.61 | -1.01 | -0.79 |
| EBITDA(a) | $95,537 | $-52,592 | $-37,813 | $-63,671 | $-50,924 |